Koji Kuronuma

5PUBLICATIONS
9CO-AUTHORS
Innate immunityMedical mycologyCondensed matter characterisation technique developmentMedical infection agents (incl. prions)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2025
Estimating the Optimal COVID-19 Booster Timing Using Surrogate Correlates of Protection: A Longitudinal Antibody Study in Naïve and Previously Infected Individuals.

Yoshihiro Fujiya, Ryo Kobayashi, Makito Tanaka

|Apr 25, 2023
Pseudo-outbreak of Mycobacterium lentiflavum at a general hospital in Japan.

Yutaro Nagano, Koji Kuronuma, Yasuo Kitamura

|Sep 23, 2022
Pneumocystis jirovecii Pneumonia Associated with COVID-19 in Patients with Interstitial Pneumonia.

Tomoyuki Takahashi, Atsushi Saito, Koji Kuronuma

|Jul 05, 2022
Role of transient receptor potential vanilloid 4 in therapeutic antifibrotic effects of pirfenidone.

Koji Kuronuma, Mitsuo Otsuka, Masato Wakabayashi

|Nov 02, 2020
CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.

Masami Kameda, Mitsuo Otsuka, Hirofumi Chiba

Pageof 1

Frequent Collaborators

1 joint publications

Takehiro Hasegawa

1 joint publications

Masato Wakabayashi

1 joint publications

Takeshi Yoshioka

1 joint publications

Yasuhide Morioka